6127 Stock Overview
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Joinn Laboratories(China)Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.24 |
| 52 Week High | CN¥23.46 |
| 52 Week Low | CN¥8.22 |
| Beta | 0.52 |
| 1 Month Change | 3.13% |
| 3 Month Change | -8.70% |
| 1 Year Change | -56.88% |
| 3 Year Change | -82.57% |
| 5 Year Change | n/a |
| Change since IPO | -81.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6127 | HK Life Sciences | HK Market | |
|---|---|---|---|
| 7D | -3.1% | -1.5% | 3.6% |
| 1Y | -56.9% | -67.1% | -10.1% |
Return vs Industry: 6127 exceeded the Hong Kong Life Sciences industry which returned -67.1% over the past year.
Return vs Market: 6127 underperformed the Hong Kong Market which returned -10.1% over the past year.
Price Volatility
| 6127 volatility | |
|---|---|
| 6127 Average Weekly Movement | 9.1% |
| Life Sciences Industry Average Movement | 11.0% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.6% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 6127's share price has been volatile over the past 3 months.
Volatility Over Time: 6127's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,510 | Dapeng Gao | www.joinn-lab.com |
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models.
Joinn Laboratories(China)Co.,Ltd. Fundamentals Summary
| 6127 fundamental statistics | |
|---|---|
| Market cap | HK$12.60b |
| Earnings (TTM) | HK$428.94m |
| Revenue (TTM) | HK$2.57b |
31.8x
P/E Ratio5.3x
P/S RatioIs 6127 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6127 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.38b |
| Cost of Revenue | CN¥1.39b |
| Gross Profit | CN¥981.55m |
| Other Expenses | CN¥584.56m |
| Earnings | CN¥396.99m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | 0.53 |
| Gross Margin | 41.30% |
| Net Profit Margin | 16.71% |
| Debt/Equity Ratio | 0% |
How did 6127 perform over the long term?
See historical performance and comparison